$VICR

VINCIARELLI PATRIZIO sold $127K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 400 shares of VICOR CORP (VICR) at $317.82 ($0.13M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 5, 2026, 4:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 4:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure may slightly affect near-term sentiment but does not provide new fundamentals or guidance.

02

Market read

A routine 10b5-1 insider sale is disclosed; traders may note it for sentiment but it is unlikely to change valuation drivers.

03

What to watch

Sale size is small relative to holdings (post-sale still ~8.7M shares), and 10b5-1 timing is not discretionary.

Relevance 6/10Novelty 6/10Timing: Filed today (2026-06-05) for a 2026-06-04 sale.

Background

SEC Form 4 reports an insider’s transaction in the issuer’s own shares; this one is an open-market sale by the CEO/Chairman under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

VICR’s Chairman/CEO sold 400 shares in an open-market transaction ($127,129) under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; at most minor, short-lived negative drift around the filing date.

Evidence & confidence

The filing is an SEC Form 4 insider transaction with explicit 10b5-1 pre-arrangement, reducing interpretability as new negative information.

Market effects

No clear sector read-through; this is company-specific insider liquidity/positioning.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can still weigh on sentiment if investors interpret it as reduced confidence.

Key entities

  • VICOR CORP

    Subject of the insider transaction disclosure (Form 4).

  • VINCIARELLI PATRIZIO

    Chairman and CEO who sold 400 shares under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: